In the context of disease, the miR-182-PKR-IFN-β axis exhibits aberrant expression level changes including elevation of miR-182, and downregulation of PKR and IFN-β levels in the PBMCs from RA patients in comparison to healthy donors. This evidence concerns the gene EIF2AK2 and rheumatoid arthritis.